AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17045887 — intervention group
Group type: COMPARATOR
Intervention: Standard PPCI
Number of subjects: 148
Study 14514747 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate with vitamin D and calcium
Number of subjects: 0
Study 14514747 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D and calcium only (Control)
Number of subjects: 0
Study 10841218 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic stenting (Wiktor stent)
Number of subjects: 211
Study 10841218 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 211
Study 9091692 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine 10 mg, 3 times per day
Number of subjects: 171
Study 9091692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 7692636 — intervention group
Group type: EXPERIMENTAL
Intervention: FK‐506
Number of subjects: 72
Study 7692636 — intervention group
Group type: COMPARATOR
Intervention: CsA
Number of subjects: 72
Study 3911367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 108
Study 3911367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg at night
Number of subjects: 108
Study 29253122 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (chemotherapy)
Number of subjects: 134428
Study 29253122 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant therapy (chemotherapy)
Number of subjects: 134428
Study 27457720 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group (insertion of needles at specified points with electrical stimulation)
Number of subjects: 72
Study 27457720 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture group (non-invasive needles adhered to skin at the same points)
Number of subjects: 72
Study 27457720 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 72
Study 27457720 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 72
Study 24374513 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreaticoduodenectomy with intraperitoneal drainage (drain group)
Number of subjects: 137
Study 24374513 — intervention group
Group type: COMPARATOR
Intervention: Pancreaticoduodenectomy without intraperitoneal drainage (no-drain group)
Number of subjects: 137
Study 22576339 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctive condition (performance determined by whichever partner stops exercising first)
Number of subjects: 58
Study 22576339 — intervention group
Group type: COMPARATOR
Intervention: Coactive condition (exercising alongside another person, independently)
Number of subjects: 58
Study 22576339 — intervention group
Group type: COMPARATOR
Intervention: Individual condition
Number of subjects: 58
Study 20485282 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium citrate (250 ml, day before procedure) followed by 2 liters PEG (day of procedure) - group 3
Number of subjects: 232
Study 20485282 — intervention group
Group type: COMPARATOR
Intervention: 4 liters PEG (day before procedure) - group 1
Number of subjects: 232
Study 20485282 — intervention group
Group type: COMPARATOR
Intervention: 2 liters PEG (day before procedure) followed by another 2 liters PEG (day of procedure) - group 2
Number of subjects: 232
Study 17564825 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered treatment
Number of subjects: 28
Study 17564825 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 28
Study 16277633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received printed self‐help materials and three‐session telephone‐based smoking cessation counselling delivered by trained counsellors
Number of subjects: 952
Study 16277633 — intervention group
Group type: COMPARATOR
Intervention: Control group received printed self‐help materials only
Number of subjects: 952
Study 16277633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 952
Study 12142115 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-adjusted warfarin (international normalized ratio 2 to 3)
Number of subjects: 70
Study 12142115 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 75 mg and clopidogrel 75 mg combination therapy
Number of subjects: 70
Study 10546382 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclocryocoagulation
Number of subjects: 5
Study 10546382 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 5
Study 7790321 — intervention group
Group type: EXPERIMENTAL
Intervention: Met‐depleting TPN with 5‐FU (500 mg/body per day; total 4.0 g/body) for 7 days before surgery
Number of subjects: 14
Study 7790321 — intervention group
Group type: COMPARATOR
Intervention: Conventional L‐methionine‐containing TPN with 5‐FU
Number of subjects: 14
Study 1693498 — intervention group
Group type: EXPERIMENTAL
Intervention: Krypton laser photocoagulation
Number of subjects: 49
Study 1693498 — intervention group
Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 49
Study 1037257 — intervention group
Group type: COMPARATOR
Intervention: amitriptyline-N-oxide
Number of subjects: 15
Study 31684880 — intervention group
Group type: EXPERIMENTAL
Intervention: Azospirillum (AL) with half dose of NP fertilizers (25 kg/ha N and 30 kg/ha P)
Number of subjects: 2
Study 31684880 — intervention group
Group type: EXPERIMENTAL
Intervention: Azotobacter (AV) with half dose of NP fertilizers
Number of subjects: 2
Study 31684880 — intervention group
Group type: EXPERIMENTAL
Intervention: Azospirillum (AL) with half dose of NP fertilizers
Number of subjects: 2
Study 31684880 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment mentioned)
Number of subjects: 2
Study 28173154 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive peritoneal lavage (10 l of saline)
Number of subjects: 600
Study 28173154 — intervention group
Group type: COMPARATOR
Intervention: Standard lavage (≤2 l of saline)
Number of subjects: 600
Study 25460215 — intervention group
Group type: EXPERIMENTAL
Intervention: Full dose mCIMT (60 h)
Number of subjects: 82
Study 25460215 — intervention group
Group type: EXPERIMENTAL
Intervention: Half dose mCIMT (30 h)
Number of subjects: 82
Study 25460215 — intervention group
Group type: EXPERIMENTAL
Intervention: Half dose bimanual therapy (30 h)
Number of subjects: 82
Study 25460215 — intervention group
Group type: COMPARATOR
Intervention: Bimanual therapy (full dose)
Number of subjects: 82
Study 23149871 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 100 mg
Number of subjects: 48
Study 23149871 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (1 mg to 100 mg doses)
Number of subjects: 48
Study 23149871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 23149871 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 48
Study 28022576 — intervention group
Group type: EXPERIMENTAL
Intervention: TJ-107 (2.5 g three times daily)
Number of subjects: 93
Study 28022576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 28022576 — intervention group
Group type: EXPERIMENTAL
Intervention: TJ-107
Number of subjects: 93
Study 19015285 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical Process Control (SPC)
Number of subjects: 0
Study 19015285 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic Regression Risk Adjusted SPC (LR-SPC)
Number of subjects: 0
Study 19015285 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian Updating Statistic (BUS)
Number of subjects: 0
Study 19015285 — intervention group
Group type: COMPARATOR
Intervention: Control arms
Number of subjects: 0
Study 19015285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arms
Number of subjects: 0
Study 19015285 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial A
Number of subjects: 0
Study 19015285 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial B
Number of subjects: 0
Study 16393192 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional treatment for drinking problems
Number of subjects: 211
Study 16393192 — intervention group
Group type: EXPERIMENTAL
Intervention: Broader treatment system including pretreatment assessment and additional forms of help
Number of subjects: 211
Study 16393192 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed change during and following treatment
Number of subjects: 211
Study 15242012 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 g/d of resistant corn starch (RS)
Number of subjects: 0
Study 15242012 — intervention group
Group type: COMPARATOR
Intervention: Regular corn starch (CS)
Number of subjects: 0
Study 11589601 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt (DSRS)
Number of subjects: 219
Study 11589601 — intervention group
Group type: COMPARATOR
Intervention: Devascularization procedure
Number of subjects: 219
Study 9066993 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg methylphenidate (MPH)
Number of subjects: 0
Study 9066993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8327853 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 16
Study 8327853 — intervention group
Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 16
Study 3548382 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 79
Study 3548382 — intervention group
Group type: COMPARATOR
Intervention: Ritodrine hydrochloride
Number of subjects: 79
Study 30868154 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored and adaptive computerized cognitive training
Number of subjects: 84
Study 30868154 — intervention group
Group type: COMPARATOR
Intervention: Generic, non-tailored computerized cognitive training
Number of subjects: 84
Study 30868154 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention
Number of subjects: 84
Study 30868154 — intervention group
Group type: COMPARATOR
Intervention: No self-efficacy condition
Number of subjects: 84
Study 29713147 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid supplementation (Aminoglutam®) administered twice a day for 4 weeks (96 kcal, 12 g amino acids, 0.18 g fat, 11.6 g carbohydrate, and vitamins B1, B6, and C)
Number of subjects: 126
Study 29713147 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid supplementation (Aminoglutam®)
Number of subjects: 126
Study 29713147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 27723227 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin peglispro (BIL)
Number of subjects: 5371
Study 27723227 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 5371
Study 24990028 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity personalized physical training (32 weeks, twice a week, optional extra session once a week)
Number of subjects: 24
Study 24990028 — intervention group
Group type: COMPARATOR
Intervention: Control group (general recommendations regarding physical activity)
Number of subjects: 24
Study 22920912 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraaortic balloon counterpulsation (IABP)
Number of subjects: 600
Study 22920912 — intervention group
Group type: COMPARATOR
Intervention: No intraaortic balloon counterpulsation (control)
Number of subjects: 600
Study 20558500 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate
Number of subjects: 24
Study 20558500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 19049698 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil
Number of subjects: 190
Study 15616230 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted, patient-centered intervention
Number of subjects: 886
Study 15616230 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 886
Study 12672146 — intervention group
Group type: EXPERIMENTAL
Intervention: Rue (Ruta chalepensis) at 50% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: EXPERIMENTAL
Intervention: Neem (Azadiracta indica) at 50% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrethrum (Chrysanthemum cinerariaefolium) at 50% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: EXPERIMENTAL
Intervention: Deet at 50% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: COMPARATOR
Intervention: Deet at 40% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: COMPARATOR
Intervention: Lemon eucalyptus at 40% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: COMPARATOR
Intervention: Pyrethrum at 40% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: COMPARATOR
Intervention: Deet at 75% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: COMPARATOR
Intervention: Lemon eucalyptus at 75% concentration
Number of subjects: 0
Study 12672146 — intervention group
Group type: COMPARATOR
Intervention: Pyrethrum at 75% concentration
Number of subjects: 0
Study 10488276 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 75
Study 10488276 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 75
Study 10488276 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 75
Study 9101929 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of RODER-loop and manual stump-sinking
Number of subjects: 140
Study 9101929 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of RODER-loop without manual stump-sinking
Number of subjects: 140
Study 9101929 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of Endo-GIA
Number of subjects: 140
Study 9101929 — intervention group
Group type: COMPARATOR
Intervention: Conventional appendectomy according to McBurney
Number of subjects: 140
Study 1680791 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine administered twice daily
Number of subjects: 34
Study 1680791 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine administered four times daily
Number of subjects: 34
Study 1680791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 6353433 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoramin (25 mg twice daily) plus hydrochlorothiazide (25 mg twice daily) or propranolol (40 mg once daily)
Number of subjects: 30
Study 31601947 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-beta1 adrenergic receptor antibody concentrations < median in STEMI patients ≤60 years
Number of subjects: 799
Study 31601947 — intervention group
Group type: COMPARATOR
Intervention: Anti-beta1 adrenergic receptor antibody concentrations > median in STEMI patients ≤60 years
Number of subjects: 799
Study 31601947 — intervention group
Group type: COMPARATOR
Intervention: All ACS patients
Number of subjects: 799
Study 29029033 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg)
Number of subjects: 324
Study 29029033 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg)
Number of subjects: 324
Study 29029033 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin (1650 mg)
Number of subjects: 324
Study 29029033 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 324
Study 29029033 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 324
Study 29029033 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 324
Study 29029033 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 324
Study 26068514 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Assessment Programme through EMS (CHAP-EMS) intervention
Number of subjects: 0
Study 26068514 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 0
Study 23816388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression
Number of subjects: 93
Study 23816388 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings
Number of subjects: 93
Study 23816388 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bypass grafts
Number of subjects: 93
Study 23816388 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE) bypass grafts
Number of subjects: 93
Study 21786549 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy group
Number of subjects: 60
Study 21786549 — intervention group
Group type: COMPARATOR
Intervention: Past procedure group
Number of subjects: 60
Study 21786549 — intervention group
Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 60
Study 19344341 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 12
Study 19344341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16700802 — intervention group
Group type: EXPERIMENTAL
Intervention: Eberconazole 1% cream every 12 h for 4 weeks
Number of subjects: 653
Study 16700802 — intervention group
Group type: COMPARATOR
Intervention: Miconazole 2% cream every 12 h for 4 weeks
Number of subjects: 653
Study 16700802 — intervention group
Group type: EXPERIMENTAL
Intervention: Eberconazole 1% cream
Number of subjects: 653
Study 16700802 — intervention group
Group type: COMPARATOR
Intervention: Miconazole 2% cream
Number of subjects: 653
Study 14715838 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol replacement
Number of subjects: 8
Study 14715838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 11283883 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose/rhamnose solution (1 mL/kg body weight) given at different time intervals after admission
Number of subjects: 23
Study 11283883 — intervention group
Group type: COMPARATOR
Intervention: Control patients (surgical controls)
Number of subjects: 23
Study 9207820 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of misoprostol (400 micrograms)
Number of subjects: 20
Study 9207820 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal administration of misoprostol (400 micrograms)
Number of subjects: 20
Study 8498608 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU dl-alpha-tocopherol (vitamin E)
Number of subjects: 21
Study 8498608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3802701 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg daily
Number of subjects: 32
Study 3802701 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily
Number of subjects: 32
Study 3802701 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 200 mg daily
Number of subjects: 32
Study 3802701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 29207087 — intervention group
Group type: EXPERIMENTAL
Intervention: p-STAT3 expression
Number of subjects: 610
Study 29207087 — intervention group
Group type: EXPERIMENTAL
Intervention: p-STAT3 expression in luminal A subtype
Number of subjects: 610
Study 29207087 — intervention group
Group type: EXPERIMENTAL
Intervention: p-STAT3 expression in luminal B subtype
Number of subjects: 610
Study 29207087 — intervention group
Group type: EXPERIMENTAL
Intervention: p-STAT3 staining by IHC
Number of subjects: 610
Study 29207087 — intervention group
Group type: EXPERIMENTAL
Intervention: p-STAT3 associated with recurrence risk
Number of subjects: 610
Study 28627356 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic therapy (AT) - 30 minutes, twice weekly for 6 months
Number of subjects: 12
Study 28627356 — intervention group
Group type: COMPARATOR
Intervention: Land-based therapy (LBT)
Number of subjects: 12
Study 26286137 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga class with yoga instructor
Number of subjects: 83
Study 26286137 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga at home
Number of subjects: 83
Study 26286137 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study 23135868 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg/day (increased to 300 mg/day)
Number of subjects: 40
Study 23135868 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 160 mg/day
Number of subjects: 40
Study 21417623 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 0
Study 21417623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19046244 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psycho-educational intervention (2.5 days)
Number of subjects: 114
Study 19046244 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 114
Study 16900245 — intervention group
Group type: EXPERIMENTAL
Intervention: Postconditioning (3 periods of 20 s of ischemia separated by 10 s of reperfusion)
Number of subjects: 10
Study 16900245 — intervention group
Group type: COMPARATOR
Intervention: Unrestricted reperfusion
Number of subjects: 10
Study 12763375 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine monotherapy after a short course of HBIg and lamivudine
Number of subjects: 46
Study 12763375 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine plus HBIg for 1 month followed by lamivudine
Number of subjects: 46
Study 10797336 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tetracycline (100 ml, 2 g)
Number of subjects: 62
Study 10797336 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 62
Study 8712323 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 0
Study 8712323 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 0
Study 8712323 — intervention group
Group type: EXPERIMENTAL
Intervention: Decamethonium
Number of subjects: 0
Study 8712323 — intervention group
Group type: COMPARATOR
Intervention: Control (uncooled arm)
Number of subjects: 0
Study 1425642 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation (5.76, 2.88 and 2.88 g per day of leucine, isoleucine and valine, respectively)
Number of subjects: 16
Study 1425642 — intervention group
Group type: COMPARATOR
Intervention: PLAC (placebo)
Number of subjects: 16
Study 3975451 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased quantity of alcohol per occasion and total lifetime consumption
Number of subjects: 0
Study 3975451 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased quantity of alcohol per occasion
Number of subjects: 0
Study 3975451 — intervention group
Group type: COMPARATOR
Intervention: Abstinence for two weeks
Number of subjects: 0